Literature DB >> 15350897

CDKs: taking on a role as mediators of dopaminergic loss in Parkinson's disease.

Patrice D Smith1, Michael J O'Hare, David S Park.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15350897     DOI： 10.1016/j.molmed.2004.07.003

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN： 1471-4914            Impact factor:   11.951


× No keyword cloud information.
  10 in total

1.  Activation of ataxia telangiectasia muted under experimental models and human Parkinson's disease.

Authors:  Antoni Camins; Javier G Pizarro; Daniel Alvira; Javier Gutierrez-Cuesta; Aurelio Vazquez de la Torre; Jaume Folch; Francesc X Sureda; Ester Verdaguer; Felix Junyent; Joaquín Jordán; Isidre Ferrer; Mercè Pallàs
Journal:  Cell Mol Life Sci       Date:  2010-05-26       Impact factor: 9.261

2.  Cell-based assays for Parkinson's disease using differentiated human LUHMES cells.

Authors:  Xiao-Min Zhang; Ming Yin; Min-Hua Zhang
Journal:  Acta Pharmacol Sin       Date:  2014-07       Impact factor: 6.150

3.  Cathepsin L induced PC-12 cell apoptosis via activation of B-Myb and regulation of cell cycle proteins.

Authors:  Xiao Shen; Yi-Fan Zhao; Shu-Qing Xu; Long Wang; Hui-Min Cao; Ying Cao; Ying Zhu; Yan Wang; Zhong-Qin Liang
Journal:  Acta Pharmacol Sin       Date:  2019-08-23       Impact factor: 6.150

4.  The Chk1/Cdc25A pathway as activators of the cell cycle in neuronal death induced by camptothecin.

Authors:  Yi Zhang; Dianbo Qu; Erick J Morris; Michael J O'Hare; Steven M Callaghan; Ruth S Slack; Herbert M Geller; David S Park
Journal:  J Neurosci       Date:  2006-08-23       Impact factor: 6.167

Review 5.  Mitochondrial fragmentation in neurodegeneration.

Authors:  Andrew B Knott; Guy Perkins; Robert Schwarzenbacher; Ella Bossy-Wetzel
Journal:  Nat Rev Neurosci       Date:  2008-07       Impact factor: 34.870

6.  Molecular modeling studies of 4,5-dihydro-1H-pyrazolo[4,3-h] quinazoline derivatives as potent CDK2/Cyclin a inhibitors using 3D-QSAR and docking.

Authors:  Yong Ai; Shao-Teng Wang; Ping-Hua Sun; Fa-Jun Song
Journal:  Int J Mol Sci       Date:  2010-09-28       Impact factor: 5.923

7.  Pyrazolo[1,5-a]-1,3,5-triazine as a purine bioisostere: access to potent cyclin-dependent kinase inhibitor (R)-roscovitine analogue.

Authors:  Florence Popowycz; Guy Fournet; Cédric Schneider; Karima Bettayeb; Yoan Ferandin; Cyrile Lamigeon; Oscar M Tirado; Silvia Mateo-Lozano; Vicente Notario; Pierre Colas; Philippe Bernard; Laurent Meijer; Benoît Joseph
Journal:  J Med Chem       Date:  2009-02-12       Impact factor: 7.446

Review 8.  Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps.

Authors:  Oren A Levy; Cristina Malagelada; Lloyd A Greene
Journal:  Apoptosis       Date:  2009-04       Impact factor: 4.677

9.  Combined kinase inhibition modulates parkin inactivation.

Authors:  Elena Rubio de la Torre; Berta Luzón-Toro; Irene Forte-Lago; Adolfo Minguez-Castellanos; Isidro Ferrer; Sabine Hilfiker
Journal:  Hum Mol Genet       Date:  2008-12-02       Impact factor: 6.150

10.  Parkinson's Disease is Associated with Dysregulations of a Dopamine-Modulated Gene Network Relevant to Sleep and Affective Neurobehaviors in the Striatum.

Authors:  Peng Jiang; Joseph R Scarpa; Vance D Gao; Martha Hotz Vitaterna; Andrew Kasarskis; Fred W Turek
Journal:  Sci Rep       Date:  2019-03-18       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.